No one cares about this stock at moment, longs or shorts.
You are,however, incorrect about the existence of a gap @ $5.
The stock may/may not dip into high $5s because of illiquidity.
It won't be for 'technical' reasons as there's clearly no $5 gap to fill.
HBV data(March-April)will move stock to ATHs or down to cash value.If you don't want risk,sell out before data readout by GILD,otherwise, it's a real lottery ticket type opportunity.I like the risk because the GILD trials(ph2s) are open label and I'd think GILD would have bailed already if the data was poor.
I would have bailed on the spike down,kpmg resignation,delisting day-probably in the $9s.Hell I didn't even have the ba-ls to buy a new position in the 8/9 range-thought we'd see $7.
It took absolute nerves of steel for those old timers here to hold their positions through that.Was/Is one of the most violent shakes I have ever witnessed. You guys deserve to wake up one morning to a $100/share acquisition bid.
This is such a shame.I am so sorry for those long timers that were hit. Management is and always has been suspect-something we spoke of frequently during the years.
I'm sure there are many like myself willing to re-invest(institutions will not let it circle the drain), but unable to do so because of an inability to quantify the scope/amount of financial exposure from the audit and an inability to assess any time frame for completion.